WIB Board of Directors
| President |
Cassidy Cantin, Consultant, Latham BioPharm Group |
| President Elect 2018 |
Rachel Kopper, Associate Director, Business Operations and Finance, Knopp Biosciences, LLC |
President Emeritus
|
Dawn Hocevar, President/CEO,CTBio
|
| Treasurer |
Debra Chamra, MA, CPA,Life Sciences Financial Consultant |
| Board Member |
Pat Larrabee, MS,President, Facility Logix, LLC
|
| Board Member |
Simone Fishburn, VP and Executive Editor, BioCentury Inc. |
| Board Member |
Paula Kasler, JD,Legal Counsel to Life Sciences Companies |
| Board Member |
Mona Chadha, MBA, Chief Strategy Officer, Bay Area at Dignity Health |
| Board Member |
Fran Schulz, BS, CPA, Partner, Ernst & Young |
| Board Member |
Debra Bowes, BS, MBEE, President, Chevy Chase BioPartners |
| Board Member |
Lily Rin-Laures,Partner at Marshall Gerstein & Borun LLP | Intellectual Property Law |
| Board Member |
Theresa McNeely,SVP, Corporate Communications and Investor Relations, Akebia Therapeutics |
| Board Member |
Dimitra Georganopoulou, PhD,Innovation and Commercialization Officer of INVO |
| Board Member |
Kristi Sarno, Senior Consultant, Latham BioPharm Group |
|
Print Page